Mary R. Shen

Mary R. Shen

Auto-generated profile, based on publicly available information

Mary R. Shen

Department of Psychiatry, Harvard Medical School

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2021 in Academic Medicine
Verified
Journal Article
Closed access
MSMary R. Shen
Mary R. Shen
ETEmma Tzioumis
Emma Tzioumis
EAElizabeth Andersen
Elizabeth Andersen
KWKathryn PhD Wouk
Kathryn PhD Wouk
RMRebecca MLS McCall
Rebecca MLS McCall
EMErin Malloy
Erin Malloy
Purpose: Research has shown that barriers to career success in academic medicine disproportionately affect women. These barriers include inadequate mentoring, which may perpetuate the underrepresentation of women in senior leadership positions. The purpose of this review was to summarize the qualitative and quantitative evidence of the impact of mentoring on women’s career outcomes and to inform future interventions to support the promotion and retention of women in academic medicine. Method: The authors conducted a systematic review of original research published in English-language, peer-reviewed journals through March 20, 2020. Search terms related to mentorship, women, and academic medicine. The authors searched MEDLINE, Embase, Scopus, Current Contents Connect via Web of Science, Cochrane Library, and PsycINFO. They excluded studies not specifically addressing women and those without gender-stratified outcomes. They extracted and analyzed the following data: study design, population, sample size, response rate, participant age, percentage of women, mentoring prevalence, and outcomes. Results: Of 2,439 citations identified, 91 studies met the inclusion criteria, including 65 quantitative and 26 qualitative studies. Mentoring was associated with objective and subjective measures of career success. Women perceived mentorship to be more valuable to their career development yet were more likely to report having no mentor. Additionally, women were more likely to report lower levels of research productivity, less career satisfaction, and greater barriers to promotion. Qualitative results indicated that women had less access to informal mentoring and family responsibilities had a greater effect on their career outcomes. Professional networking, female mentors, and relational aspects of mentoring were common themes. Conclusions: This review examined gender disparities in mentoring and the impact on research productivity, promotion success, and career satisfaction for women in academic medicine. Institution-supported mentoring programs are needed to facilitate identification of appropriate mentors and promotion of a more equitable academic career environment for women.

14 May 2022 in Journal of Surgical Education
Verified
Journal Article
Closed access
MSMary R. Shen
Mary R. Shen
LZLucy Zhuo
Lucy Zhuo
KMKerry Madison
Kerry Madison
BBBrooke C. Bredbeck
Brooke C. Bredbeck
MKMichael T. Kemp
Michael T. Kemp
GKGifty Kwakye
Gifty Kwakye

1 August 2024 in Journal of Addiction Medicine
Verified
Journal Article
Closed access
MSMary R. Shen
Mary R. Shen
KOKwadwo Owusu-Boaitey
Kwadwo Owusu-Boaitey
LHLaura M. Holsen
Laura M. Holsen
JSJoji Suzuki
Joji Suzuki
Substance use disorder (SUD) continues to be a leading cause of morbidity and mortality with limited treatments. There is interest in expanding the use of GLP-1 agonists in treating SUD. However, evidence for safety and efficacy in humans is limited. This review aims to bridge the existing knowledge gap by establishing a baseline of literature in this area to inform future trials and clinical practice. Our inclusion criteria were English peer-reviewed manuscripts reporting on use of GLP-1, GIP, and/or glucagon receptor agonists in treatment of SUDs, excluding case studies. The literature search was performed in accordance to PRISMA guidelines. Five studies were included in this review examining the use of this medication in tobacco use disorder, alcohol use disorder, and cocaine use disorder. No studies regarding substance withdrawal syndrome were identified. The included studies varied widely in terms of patient selection, dose/formulation of GLP-1 agonists, and follow-up. The results of this scoping review are mixed, with 3 studies demonstrating positive results and 2 studies finding no efficacy of this medication on SUD outcomes. It is premature to prescribe this medication off-label to patients. Further research is needed to determine the efficacy of GLP-1 agonists in treating SUD.

6 April 2024 in Surgery for Obesity and Related Diseases
Verified
Journal Article
Closed access
MSMary R. Shen
Mary R. Shen
MHMaya M. Hammoud
Maya M. Hammoud
ABAaron J. Bonham
Aaron J. Bonham
BABryan Aaron
Bryan Aaron
AGAmir A. Ghaferi
Amir A. Ghaferi
JFJonathan F. Finks
Jonathan F. Finks

4 May 2022 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
MSMary R. Shen
Mary R. Shen
SJShannon Jiang
Shannon Jiang
MMM. Andrew Millis
M. Andrew Millis
SBSidra N. Bonner
Sidra N. Bonner
ABAaron J. Bonham
Aaron J. Bonham
OVOliver A. Varban
Oliver A. Varban

1 December 2019 in Annals of Surgery
Verified
Journal Article
Open access
MSMary R. Shen
Mary R. Shen
JWJennifer F. Waljee
Jennifer F. Waljee